Rep. Kevin Hern (R-OK) Sells UnitedHealth (UNH) Stock

Oklahoma Congressman Kevin Hern sold shares of UnitedHealth Group Incorporated (NYSE: UNH) valued between $15,001 and $50,000 on September 10, 2026. The transaction was reported on September 25, 2026, and occurred when the stock was trading at approximately $402.35.

Inside Kevin Hern's Trade

Hern's sale comes as part of his regular stock transactions and does not imply any specific outlook on the company's performance. The reported value of his shares suggests a significant stake, reflecting a range between $15,001 and $50,000 in market value.

Other Institutional Activity in UnitedHealth Group

Several major institutional investors have made adjustments to their holdings in UnitedHealth Group. Blackrock Inc. grew its holdings by 3,394,259 shares, ending with about 76.9 million shares worth approximately $30.9 billion. Vanguard Capital Management LLC added 441,525 shares, bringing its total to about 59.3 million shares valued at roughly $23.8 billion. State Street Corporation increased its stake by 299,205 shares, resulting in 45.6 million shares worth about $18.3 billion. Additionally, Capital World Investors gained 2,103,297 shares, totaling about 29.9 million shares valued at around $12 billion. FMR, LLC saw a substantial increase, adding 15,974,192 shares to reach nearly 27.9 million shares worth about $11.2 billion.

UnitedHealth Group Incorporated Stock Up 1.7%

As of publication, UnitedHealth Group shares traded at $402.35, slightly below its 52-week high of $461.62. The stock is in the midst of a challenging period, having fallen from recent peaks, though it has maintained a solid position well above its 52-week low of $255.97.

Recent Earnings

In its latest earnings report, UnitedHealth Group posted revenue of approximately $450 billion, which showed a slight decline from the previous year. The company’s earnings per share (EPS) was $15.55, with a net margin of 3.53%. The next earnings report is scheduled for January 26, 2027.

Analysts Set New Price Targets

On October 16, 2026, Bernstein maintained its Outperform rating on UnitedHealth Group, setting a price target of $500, down from $512. JP Morgan also kept its Overweight rating with a new target of $524, up from $516. TD Cowen reiterated its Hold rating with a consistent target of $402, while Piper Sandler and Barclays maintained their Overweight ratings with targets of $504 and $440, respectively.

About UnitedHealth Group

UnitedHealth Group is a leading healthcare company that operates in the U.S. and internationally. It provides various health services through its segments: Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. The company is headquartered in Eden Prairie, Minnesota, and employs around 390,000 people.

Bottom Line

Looking ahead, investors will keep an eye on UnitedHealth Group's next earnings report on January 26, 2027. This sale by Rep. Hern reflects ongoing activity under the STOCK Act, and the company's performance will be closely watched by analysts and stakeholders alike.